Mednax, Inc.

Case Details

Class Period:
February 4, 2016 – July 27, 2017
Date Filed:
July 10, 2018
Case Number:
Southern District of Florida

Case Summary

The complaint alleges that during the Class Period, Mednax violated the Exchange Act by misleading investors regarding the sustainability of the Company's business model. Throughout the Class Period, Mednax's business model depended upon growth from the acquisition of new practice groups, primarily in anesthesiology. In truth, Mednax's business model is not sustainable and its growth was based upon suppressing physician compensation and enforcing non-compete agreements to deter physician defections. When the truth regarding the sustainability of Mednax's business model was finally revealed at the end of the Class Period, the price of the Company's stock had declined by over 23%.

Action Details

View Complaint (pdf)

Send Information

If you have information regarding this case that you would like to make available, please click here to contact us.